eGnome

NIPT

Why EG NIPT PRO is Essential for Your Prenatal Care

Early Detection of Genetic Disorders
With EG NIPT PRO, you can screen for potential genetic conditions early in your pregnancy. Non-Invasive Prenatal Testing (NIPT) plays a crucial role in improving public health and prenatal care. This allows you to be better informed and prepared, ensuring the best possible care for you and your baby.

The key benefits include:

  • Early Detection of Genetic Disorders

    By identifying genetic disorders early, expectant parents can make informed decisions about their pregnancy management.

  • Risk Reduction

    EG NIPT PRO is a safer alternative to invasive procedures like amniocentesis, significantly minimizing risks to both mother and fetus.

  • Public Health Benefits

    Reducing the incidence of undiagnosed genetic disorders helps lower healthcare costs and improves population health outcomes.

  • Alleviating the Burden of Genetic Disorders

    Early diagnosis and intervention can enhance the quality of life for affected individuals and reduce the strain on families and healthcare systems.

It’s important to note that EG NIPT PRO is a screening test, which assesses the risk of certain conditions rather than providing a definitive diagnosis. Positive results should be followed up with diagnostic testing for confirmation.

Pioneering Enhanced Genetic Screening with 3rd Generation Technology

EG NIPT PRO introduces cutting-edge NIPT services by leveraging third-generation sequencing. This advanced technology allows for more comprehensive genetic screening, providing superior accuracy and a broader detection range.

How Likely Are You to Find Something?

Risk Assessment

With EG NIPT PRO, the likelihood of identifying at least one genetic disorder is approximately 1 in 58 pregnancies, with a 1.73% risk factor.
This makes it an essential tool in understanding your baby’s genetic health.

What Does EG NIPT PRO Screen For?
1.Aneuploidy Screening

EG NIPT PRO detects abnormalities in chromosome numbers, identifying conditions like

  • Down Syndrome (Trisomy 21)
    An extra chromosome 21.
  • Edwards Syndrome (Trisomy 18)
    An extra chromosome 18.
  • Patau Syndrome (Trisomy 13)
    An extra chromosome 13.
  • Turner Syndrome
    A missing X chromosome.
  • Triple X Syndrome
    An extra X chromosome in females.
  • Klinefelter Syndrome (XXY)
    An extra X chromosome in males.
  • XYY Syndrome
    An extra Y chromosome in males.
2. Genomic Variations Analysis

This test also analyzes structural variations across the entire genome, providing deep insights into various genetic disorders and chromosomal anomalies.

  • Cystic Fibrosis
    A genetic disorder affecting the lungs and digestive system.
  • Sickle Cell Anemia
    A blood disorder causing red blood cells to assume a sickle shape, leading to various health issues.
  • Tay-Sachs Disease
    A fatal genetic disorder that destroys nerve cells in the brain and spinal cord.
  • Phenylketonuria (PKU)
    A metabolic disorder where the body cannot break down the amino acid phenylalanine.
  • Huntington's Disease
    A degenerative brain disorder that affects movement, cognition, and emotions.
  • Marfan Syndrome
    A connective tissue disorder affecting the heart, eyes, and skeleton.
  • Neurofibromatosis Type 1 (NF1)
    Causes tumors to grow on nerve tissue.
  • Neurofibromatosis Type 2 (NF2)
    Leads to benign tumors on the nerves controlling hearing and balance.
  • Duchenne Muscular Dystrophy
    A severe form of muscular dystrophy primarily affecting boys.
  • Hemophilia A
    A bleeding disorder due to a deficiency in clotting factor VIII.
  • Hemophilia B
    Similar to Hemophilia A, but caused by a deficiency in clotting factor IX.
  • 22q11.2 Deletion Syndrome (DiGeorge Syndrome)
    Causes heart defects, immune issues, and developmental delays.
  • 1p36 Deletion Syndrome
    Leads to intellectual disability and seizures.
  • Angelman Syndrome
    Affects the nervous system, causing developmental delays and speech impairments.
  • Prader-Willi Syndrome
    Causes insatiable appetite, leading to obesity, and intellectual disability.
  • Mitochondrial Myopathies
    Affects mitochondria, leading to muscle weakness and neurological issues.
  • Leber's Hereditary Optic Neuropathy (LHON)
    Causes sudden vision loss due to optic nerve degeneration.
  • BRCA1 and BRCA2 Mutations
    Increases risk of breast and ovarian cancers.
  • Lynch Syndrome
    Increases risk of colon and other cancers.
Frequently Asked Questions (FAQ)
  • Q: When should I consider taking the EG NIPT PRO test?

    A: EG NIPT PRO is typically recommended from the 10th week of pregnancy onwards. It’s suitable for all pregnant women, especially those at higher risk of chromosomal abnormalities due to factors like advanced maternal age (35 years or older), a family history of genetic conditions, or abnormal results from other prenatal screenings. It’s also a good choice for expectant parents seeking early reassurance about their baby’s genetic health.

  • Q: Is EG NIPT PRO risky?

    A: EG NIPT PRO is very safe because it is non-invasive. The test requires only a blood sample from the mother, posing no risk to the fetus. Unlike invasive procedures such as amniocentesis, which carry a small risk of miscarriage, EG NIPT PRO does not involve such risks, making it a preferred option for initial prenatal screening.

  • Q: Is EG NIPT PRO always correct?

    A: While EG NIPT PRO is highly accurate, it is not infallible. It is a screening tool, meaning it assesses the risk of certain genetic conditions but does not provide a definitive diagnosis. There are rare instances of false positives (indicating a high risk of a condition that is not present) and false negatives (missing a condition). For this reason, any high-risk result should be confirmed with further diagnostic testing.

  • Q: What if EG NIPT PRO cannot make an assessment?

    A: In some cases, EG NIPT PRO may not be able to provide a conclusive result. This can happen if there is insufficient fetal DNA in the mother’s blood sample, which is more likely earlier in pregnancy or in cases where the mother has a higher body weight. If EG NIPT PRO cannot make an assessment, please, contact us.

Lead the Future of Prenatal Genetic Screening

By introducing this state-of-the-art our NIPT service, your organization will position itself as a trailblazer in prenatal genetic screening, both domestically and globally. This service will transform the quality of your healthcare offerings, providing expectant parents with the most comprehensive and precise genetic information available, and setting a new standard in the industry.